The 24th World Pharmaceutical Raw Materials China Exhibition (CPHI China 2026) has successfully concluded on June 18th at the Shanghai New International Expo Center. This exhibition brings together more than 3600 exhibitors from around the world and over 110000 professional merchants from home and abroad, covering the entire industry chain of active pharmaceutical ingredients, pharmaceutical intermediates, formulation technology, biopharmaceuticals, contract production, laboratory equipment, and pharmaceutical machinery packaging.
Hubei Xindesheng Material Technology Co., Ltd. made a heavyweight debut with its core product lineup, and received numerous domestic and foreign merchants during the three-day exhibition period. With its strength in hard core products and one-stop raw material solutions, it received numerous inquiries and cooperation intentions, successfully completing the exhibition journey.
The popularity of the booth continues to rise, and domestic and foreign merchants are deeply negotiating
The three-day exhibition attracted a continuous flow of visitors to the New Desheng booth, including overseas buyers, domestic IVD companies, small and medium-sized reagent manufacturers, and technical engineers from research institutes. The on-site sales and technical R&D team is stationed throughout the entire process, providing one-on-one product parameter explanations, application scenario matching, and answering process questions for customers. They also provide customized raw material solutions for customer reagent kit development, capacity expansion, and cost optimization needs.
Hubei Xindesheng's full matrix exhibits debut
Hubei Xindesheng Material Technology Co., Ltd. was registered and established in 2017 (formerly known as Wuhan Desheng Biochemical Technology Co., Ltd. established in 2005). The company is headquartered in Guanggu United Science and Technology City, Gedian Development Zone, Ezhou City, Hubei Province, and has two research and development production bases, Gedian (54 acres) and Huanggang (70 acres), with an annual production capacity of 5000 tons for all categories. The core product system of this exhibition covers IVD in vitro diagnostics, biomedicine, daily chemical and other fields:
Hubei Xindesheng Blood Vessel Reagent has over 20 types of products and supports one-stop procurement. Based on the advantages of chemical synthesis technology, more than 50 product matrices such as TRIS, HEPES, MOPS, etc. have been formed using biological buffering agents, with a stable purity of over 99%. The indicators can be customized according to customer application scenarios. TOOS, MAOS and other products in chromogenic substrates have surpassed some indicators compared to well-known foreign companies, helping reagents improve detection indicators and reduce background interference. Together with chemiluminescence reagents and enzyme preparations, they have been widely used in various types of in vitro diagnostic kits. With the commissioning of the new Huanggang factory, the production capacity of biological buffering agents and carbomers has been significantly increased, providing more stable and efficient supply guarantees for fields such as biomedicine and daily chemical products.
The exhibition has come to an end, and cooperation is not limited. We look forward to continuing to work together for a win-win situation
Thank you to all the new and old customers and industry colleagues who have come to the booth for negotiations! We are always waiting for inquiries both online and offline, looking forward to future in-depth cooperation.
In the future, Hubei Xindesheng will continue to increase research and development innovation, empower the development of industries such as IVD in vitro diagnostics, biomedicine, and daily chemical products with more stable products and professional technical support, and help upgrade the human health industry!
